Company: BNBX
Filing Date: 2025-02-14
Form Type: 8-K
Source: 0001104659-25-014243
Chunk: 0

Company: BNB PLUS CORP.
Filing Date: 2025-02-14
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07      Submission of Matters to a Vote of Security Holders.  

On February 14, 2025, Applied DNA Sciences, Inc.
(the “ Company”) reconvened its special meeting of stockholders (the “ Special Meeting”) which was originally
held on January 23, 2025 and adjourned. At the Special Meeting, an aggregate of 16,020,694 shares of the Company’s common stock
(“ Common Stock”) were present in person or by proxy and entitled to vote, which did not constitute a quorum
determined in accordance with the Company’s By-Laws, which requires one-third of the Company’s issued and outstanding
shares of Common Stock. Accordingly, no action was taken with respect to the proposal presented at the Special Meeting, and the Special
Meeting was adjourned for a second time until February 28, 2025, at 11:00 a. m. in order to permit additional solicitation of stockholders
and to allow stockholders additional time to vote on the sole proposal under consideration at the Special Meeting.

As previously reported on its Form 8-K filed on
October 31, 2024, the Company closed on such date a registered direct public offering and concurrent private placement (the “ Offering”)
of common stock, series C and D common stock purchase warrants (the “ Series Warrants”) and placement agent warrants (“ Placement
Agent Warrants”, and, with the Series Warrants, the “ Private Placement Warrants”). The Private Placement Warrants
will only be exercisable upon receipt of such stockholder approval as may be required by the applicable rules and regulations of the Nasdaq
Capital Market (the “ Warrant Stockholder Approval”). Further, pursuant to the terms of the Securities Purchase Agreement
entered into in connection with the Offering, if the Company does not obtain Warrant Stockholder Approval at the Special Meeting, as adjourned,
it will be obligated to call a subsequent stockholder meeting to seek to obtain Warrant Stockholder Approval.

SIGNATURES